Aims/hypothesis. One subtype of MODY (MODY3) results from the heterozygous mutation of a hepatocyte nuclear factor (HNF)-1α. The pattern of HNF-1α expression in the normal pancreas has not been determined. This study aimed to clarify the profile of HNF-1α protein expression in the developing mouse pancreas. Methods. Double immunofluorescence staining was carried out for HNF-1α and pancreatic hormones or transcription factors (PDX-1, Pax6, Isl1, and Nkx2.2). The expression of these transcription factors was also studied in the beta cells of HNF-1α mutant mice. Results. HNF-1α was expressed by both endocrine and exocrine cells of the pancreas. Double immunofluorescence staining showed that HNF-1α was expressed in the nuclei of alpha cells, beta cells, delta cells, and pancreatic polypeptide (PP) cells. HNF-1α was first detected in most pancreatic epithelial cells on embryonic day 10.5 (E10.5), and hormone-positive endocrine cells and amylase-positive cells expressed HNF-1α on E15.5. Most of the Pax6-, Isl1-, or PDX-1-positive cells showed co-expression of HNF-1α. However, HNF-1α immunoreactivity was not observed in 36.0% of Nkx2.2-positive cells. Expression of Nkx2.2, Isl1 and Pax6 seemed to be normal in the beta cells of transgenic mice with dominant negative overexpression of HNF-1α. Expression of PDX-1 did not change in the beta cells of pre-diabetic HNF-1α (-/-) mice, but expression was markedly decreased in the diabetic stage. Conclusion/interpretation. HNF-1α is expressed by both endocrine cells and exocrine cells of the pancreas from the foetal stage along with other transcription factors, so HNF-1α might play a role during development. [Diabetologia (2002[Diabetologia ( ) 45:1142[Diabetologia ( -1153 
domains: an amino-terminal dimerisation domain, a DNA-binding domain with homeodomain-like and POU-like motifs, and a COOH-terminal transactivation domain. Although HNF-1α was initially identified as a hepatocyte-specific transcription factor, it is known also to be expressed in the pancreas [3, 4, 5, 6] . We have found that heterozygous mutations of the HNF-1α gene cause a form of maturity-onset diabetes of the young (MODY3) [7] and clinical studies have shown that MODY3 is characterized by impaired insulin secretion [8, 9] , suggesting an important role of HNF-1α in pancreatic beta cells. Because the pancreas is composed of four kinds of endocrine cells as well as exocrine cells, we need to determine which cells in the pancreas express HNF-1α. The MODY3 phenotype suggests that HNF-1α should be expressed by pancreHepatocyte nuclear factor-1α (HNF-1α) is a homeodomain-containing transcription factor that regulates the expression of a large number of liver-specific genes [1, 2] . HNF-1α protein is highly conserved among mammals and is composed of three functional atic beta cells. It has already been reported that HNF-1α expression can be detected in insulinoma cells [10, 11] but the exact cells expressing HNF-1α in the normal pancreas have not been determined. In addition, it is not known whether HNF-1α is expressed in the developing pancreas. A number of transcription factors are initially expressed during embryogenesis and these factors control the differentiation of pancreatic endocrine and exocrine cells [12, 13, 14] . Although HNF-1α is involved in insulin secretion [15, 16, 17, 18, 19] , it might have an additional role during the development of the pancreas. Thirdly, a cascade of transcription factors controls the development of pancreatic beta cells [14, 20, 21] . Earlier studies have shown neurogenin-3 and Nkx2.2 are expressed in endocrine cells in the early stage, while Isl1 and Pax6 are expressed by relatively mature endocrine cells [20, 21, 22, 23, 24, 25, 26] . If HNF-1α is expressed in the developing pancreas, what is its position in the developmental transcription cascade? In this study, we investigated the expression of MODY3/ HNF-1α protein during pancreatic development.
Materials and methods
Transfection and western blot analysis. Eight micrograms of pcDNA3.1-HNF-1α or empty pcDNA3.1 expression plasmid was transfected into COS-7 cells with Lipofectamine plus reagent (Life Technologies, Tokyo, Japan). Nuclear proteins were extracted 48 h after transfection [27] . Nuclear proteins of mouse hepatocytes were extracted as described previously [28] . COS-7 protein (20 µg) or hepatocyte protein (40 µg) was subjected to 10% SDS-polyacrylamide gel electrophoresis and transferred by electroblotting to an Immobilon-P membrane (Millipore, Bedford, Mass., USA). The membrane was incubated with goat polyclonal anti-HNF-1α antibody (N-19, Santa Cruz, Calif., USA) for 12 h at 4°C and then was incubated further with horseradish peroxidase (HRP)-conjugated anti-goat IgG antibody. Bands were visualised with ECL western blotting detection reagents (Amersham Pharmacia Biotech, Buckinghamshire, UK). To test the specificity of the anti-HNF-1α antibody, it was incubated with an excess of HNF-1α peptide (VSKLSQLOTELLAALLESGC) (Santa Cruz), which was the peptide used for the immunisation. Western blot analysis was also done using the antibody after absorption.
Animals and sample preparation. Under general anesthesia, ten-week-old C57BL/6J Jcl mice were perfused with 4% paraformaldehyde (PFA) in 0.1 mol/l phosphate buffer (PB). After isolation, the liver, kidney, heart, brain, and pancreas were fixed in the solution for 6 h. Pregnant C57BL/6J Jcl mice were purchased from Clea Japan (Tokyo, Japan). The morning when the vaginal plug was detected was designated as embryonic day 0.5 (E0.5). Embryos were harvested from E9.5 to E18.5. The pancreas of each embryo was fixed in 4% PFA/0.1 mol/l PB for 6 h, followed by cryoprotection in serial sucrose solutions (5-30%) at 4°C and freezing for storage. Consecutive sections (6 µm thick) were cut and collected on glass slides for examination. Transgenic mice with a dominant negative overexpression of mutant human HNF-1α (P291fsinsC-HNF-1α) in beta cells and HNF-1α null mice have been described [16, 18, 19] . The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Osaka University. . The HNF-1α signal was amplified by applying biotinylated donkey anti-goat antibody (Chemicon). Biotinylated secondary antibodies were detected with Alexa Flour 488-conjugated streptavidin (Molecular Probes) or the ABC Elite immunoperoxidase system (Vector, Burlingame, Calif., USA). Peroxidase activity was detected with a Liquid DAB Substrate Kit (Zymed, South San Francisco, Calif., USA) or a VIP Substrate Kit (Vector). A goat antimouse IgG Fab fragment (1:5 Jackson ImmunoResearch Laboratories, West Grove, Penn., USA) or a Histomouse-Plus Kit (Zymed) was used to block non-specific staining by endogenous mouse immunoglobulins. Samples were viewed under a light microscope (PROVIS AX80T, Olympus, Tokyo, Japan) or a confocal microscope (LSM510, Zeiss, Jena, West Germany). Cell counting. Three sections cut at 60 µm intervals from each E15.5 pancreas were double stained for HNF-1α and transcription factors (PDX-1, Isl1, Pax6, and Nkx2.2). Then, the number of cells co-expressing HNF-1α and other transcription factors was counted.
Results
Detection of HNF-1α protein by western blot analysis. COS-7 cells, which do not possess endogenous HNF-1α, were transfected with the HNF-1α expression plasmid, when western blot analysis was done with a polyclonal HNF-1α antibody (Fig. 1A) , a single band corresponding to HNF-1α protein (73 kDa) was detected. This band was lost after pre-incubation of the antibody with an excess of the HNF-1α peptide used for immunisation, suggesting that the antibody specifically recognized HNF-1α protein. This antibody could detect endogenous HNF-1α in mouse hepatocytes (Fig. 1B) .
Expression of HNF-1α protein in adult mouse tissues. HNF-1α immunoreactivity was detected in hepatocyte nuclei and in the proximal tubules of the kidney in adult mice. In contrast, no immunoreactivity was detected in the bile duct or the glomeruli of the kidney ( Fig. 2A, B) . HNF-1α staining was also detected in the stomach and intestine, but was not detected in the brain and heart. This restricted pattern of HNF-1α staining was compatible with the reported tissue distribution of HNF-1α mRNA [3, 4, 5, 30, 31] and β-galactosidase expression of HNF-1α (+/-) mice [6] . Furthermore, HNF-1α immunoreactivity was absent from the nuclei of hepatocytes in HNF-1α (-/-) mice (Fig. 2C, D) . These data suggested that this antibody could correctly recognize HNF-1α. Next, we tested the pancreatic expression of HNF-1α using the antibody. As a result, HNF-1α protein was detected in both endocrine and exocrine cells. Double immunofluorescent staining for HNF-1α and endocrine hormones showed that HNF-1α was expressed in the nuclei of glucagon-positive alpha cells, insulin-positive beta cells, somatostatin-positive delta cells, and pancreatic polypeptide (PP) cells (Fig. 3) . However, HNF-1α staining was not found in the nuclei of the pancreatic duct cells.
Time course of pancreatic HNF-1α expression in the developing mouse. RT-PCR analysis showed HNF-1α mRNA is expressed in the mouse pancreas at E15.5. To assess the pattern of HNF-1α expression in the embryonic pancreas more precisely, immunohistochemical analysis was done at different times. HNF-1α expression could hardly be detected in the pancreas at E9.5. However, HNF-1α was found in most epithelial cells on day E10.5, and staining was more intense by E11.5 (Fig. 4) . During the second transition (from stage E13.0 [32] ), the duct termini differentiate into exocrine cells and the endocrine cells start to form clusters. The duct epithelium formed branching structures around E13.5 and cells with a relatively high intensity of HNF-1α staining were detected at the periphery of the duct epithelium or adjacent to it (Fig. 4E) . At E15.5-16.5, strong HNF-1α staining was observed in differentiated acinar cells with a polarised appearance but HNF-1α expression was weak in the duct epithelium. Nuclear staining for HNF-1α showed a decrease of intensity on E17.5 but HNF-1α staining was still found in acinar cells and mature islet cells. The pattern of expression was similar on E18.5, which was one day prior to birth.
In 10-week-old mice, HNF-1α was expressed by alpha cells, beta cells, delta cells, and PP cells (Fig. 3) . We also examined the types of HNF-1α-positive cells in the developing pancreas. On E15.5, HNF-1α was expressed in alpha cells, beta cells, and delta cells (Fig. 5) . Expression of HNF-1α in PP cells could not be tested because PP cells had not appeared at this stage [33] . Double staining for amylase and HNF-1α indicated that HNF-1α was also expressed by amylase-positive exocrine cells.
Position of HNF-1α in the sequence of transcription factor expression.
To understand the position of HNF-1α in the sequence of transcription factor expression, we did double staining of E15.5 pancreases for HNF-1α and various transcription factors (PDX-1, Pax6, Isl1, and Nkx2.2) (Fig. 6) . PDX-1 is a homeodomain-containing transcription factor [34] , and its pancreatic targeted disruption results in the failure of pancreatic development in mice [35] . Pax6 is a transcription factor containing a paired box and homeodomain, and is an essential determinant of the fate of endocrine cells [26] . Isl1 is a member of the LIM ho- meodomain transcription factor family. Isl1 null mice show early blocking of the differentiation of endocrine cells in the pancreas [22, 36] . Nkx2.2 contains an NKhomeodomain and its expression can be detected in alpha, beta, and PP cells, but not in delta cells or exocrine cells [37] . It has been reported that 70 to 80% of Nkx2.2-positive cells co-express a proendocrine marker, ngn3 [25] . We found that most PDX-1-positive (98.0%) and Pax6-positive cells (98.0%) co-expressed HNF-1α, although a few PDX-1 + /HNF-1α -or Pax6 + /HNF-1α -cells were still observed. 10.1% of Isl1-positive cells were negative for HNF-1α expression. In contrast, Nkx2.2 + /HNF-1α -cells were readily detected and only 64.0% of the Nkx2.2 cells showed co-expression of HNF-1α. A similar pattern of expression was also found on E11.5. In a recent study, we generated beta cell-targeted transgenic mice with overexpression of a dominant negative human P291fsinsC-HNF-1α mutant that suppressed endoge- nous HNF-1α activity in pancreatic beta cells. Expression of Nkx2.2, Isl1, Pax6 and PDX-1 appeared to be normal in the beta cells of transgenic mice (Fig. 7) [19]. We also confirmed that PDX-1 expression remained unchanged in the beta cells of 2-week-old HNF-1α (-/-) mice (Fig. 8) . Earlier studies have placed Nkx2.2 upstream of Isl1 and Pax6 in the major pathway of beta-cell differentiation [25] . Taken together, these data suggest that HNF-1α expression occurs after the expression of PDX-1, Nkx2.2, Isl1, and Pax6 in developing beta-cells. However, PDX-1 expression was markedly decreased in HNF-1α null mice after the onset of diabetes (Fig.8F) , suggesting a secondary effect of hyperglycaemia. In fact, down- regulation of PDX-1 by hyperglycaemia has been reported [38, 39] .
Discussion
We have shown that HNF-1α was expressed by endocrine cells as well as exocrine cells of the pancreas (A, C, E, G) . Expression of PDX-1 by beta cells from 2-week-old pre-diabetic HNF-1α (-/-) mice was comparable to that by control (+/+) mice (A, B) . In contrast, expression of PDX-1 was markedly reduced in 6-week-old mice after the onset of diabetes (E, F) from the developmental stage. PDX-1 expression is limited to beta cells and delta cells in adult mice [40] , whereas Nkx2.2 is expressed by alpha cells, beta cells, and PP cells, but not delta cells [37] . In contrast, HNF-1α was expressed by all four kinds of endocrine cells, so it could regulate non-beta cells as well as beta cells in the pancreas. We previously reported that glucagon secretion was also impaired along with that of insulin in a MODY3 patient [41] . Isl1 and Pax6 are known to be expressed by all kinds of endocrine cells [22, 26] but exocrine cells do not express these transcription factors. Since HNF-1α is strongly expressed by acinar cells, it might also be involved in the regulation of exocrine function. Serum concentrations of amylase and lipase were normal in a MODY3 patient [42] but the exocrine function of these patients were not examined in more detail.
HNF-1α expression in the mouse pancreatic epithelium could first be clearly detected on embryonic day 10.5, so its initial expression was delayed when compared with that of PDX-1 (E8.5) [34, 35, 43] , Isl1 (E9.0) [22] , and Pax6 (E9.0) [44] , and Nkx2.2 (E9.5) [37] . Nkx2.2 is expressed by undifferentiated proendocrine cells [25] . In contrast, Isl1 and Pax6 are expressed by more differentiated endocrine cells [21, 25] . Our results suggest that HNF-1α is expressed after the transcription factors PDX-1, Isl1, Pax6, and Nkx2.2. Earlier studies have suggested that the sequence of the transcription factor expression in betacell development as follows: ngn3 on -neuroD on -Isl1 onPax6 on -ngn3 off -PDX-1 high -insulin on [21] . Accordingly, we presume that HNF-1α fits into this sequence as follows: ngn3 on -neuroD on -Isl1 on -Pax6 on -ngn3 off -PDX-1 high -HNF-1α on -insulin on . We and others have already suggested that HNF-1α could be directly involved in transactivation of the insulin gene [11, 17, 45] and the predicted position of HNF-1α in the sequence would be compatible with this concept. In good accordance with the findings, PDX-1 expression is not reduced in beta cells of HNF-1α mutant mice ( [19, 46] and this study) and dominant negative suppression of HNF-1α activity in INS-1 cells does not affect the levels of PDX-1 and neuroD mRNA [17] . However, a previous study using RT-PCR suggested that PDX-1 expression was reduced in HNF-1α (-/-) mice [47] . Since the number of beta cells is decreased in the islets of HNF-1α null mice [15, 16] , a reduced number of beta cells that express PDX-1 might be a possible explanation for the reduced expression of PDX-1 in the islets. Secondary down-regulation of PDX-1 by hyperglycaemia [38, 39] might also account for the discrepancy. It is not clear whether PDX-1 directly regulates the expression of the HNF-1α gene transcription; therefore the regulation of HNF-1α by other transcription factors should be examined. Recent studies have suggested that HNF-1α regulation in the pancreas is more complex rather than a simple linear hierarchy [47, 48] .
In summary, we clarified the profile of HNF-1α expression in the adult and embryonic mouse pancreas. Since HNF-1α expression was first detected during the development of the pancreas, it might have some functional role in this process. For example, the pancreatic islets of HNF-1α null mice and transgenic mice with overexpression of dominant negative HNF-1α were small and irregular in shape. E-cadherin-mediated cell adhesion is important for the proper organisation of the pancreatic islets [49] and HNF-1α has been suggested to have a role in E-cadherin expression by islet cells [19] . The role of HNF-1α in the beta cells during pancreatic development need to be clarified to understand better the molecular basis of HNF-1α diabetes.
